Paper Details

  1. Home
  2. Paper Details

Systemic treatments for metastatic cutaneous melanoma.

Author: Chiarion SileniVanna, HadjinicolaouAndreas V, MocellinSimone, PasqualiSandro, RossiCarlo Riccardo

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Metastatic melanoma, a type of skin cancer that has spread, previously had a poor outlook. However, new medications like immune checkpoint inhibitors and targeted therapies have significantly improved survival for some patients, changing how melanoma is treated.
Paper Details　
Original Abstract of the Article :
The prognosis of people with metastatic cutaneous melanoma, a skin cancer, is generally poor. Recently, new classes of drugs (e.g. immune checkpoint inhibitors and small-molecule targeted drugs) have significantly improved patient prognosis, which has drastically changed the landscape of melanoma th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491081/

データ提供：米国国立医学図書館（NLM）

A New Era in Melanoma Treatment: Emerging from the Desert of Despair

The field of oncology is constantly striving to find more effective treatments for cancer. This research provides an overview of the systemic treatments for metastatic cutaneous melanoma, a type of skin cancer. The researchers discuss the recent advancements in melanoma treatment, highlighting the emergence of new drug classes that have significantly improved patient outcomes.

A Shifting Landscape: Finding Oasis in the Desert of Melanoma

The emergence of new drug classes, such as immune checkpoint inhibitors and small-molecule targeted drugs, has drastically changed the landscape of melanoma treatment. These advancements offer a glimmer of hope in the fight against this challenging disease. Imagine finding an oasis in a desolate desert, offering refuge and a chance for survival.

The Future of Melanoma Treatment: Continuing the Journey Through the Desert

The researchers emphasize the importance of ongoing research and development to further improve treatment options and patient outcomes. The desert of melanoma treatment is vast and constantly evolving, but with each new discovery, we move closer to finding a cure for this devastating disease. It's a journey filled with hope, resilience, and determination to overcome this challenge.

Dr.Camel's Conclusion

This research highlights the significant progress made in melanoma treatment, with new drug classes offering a brighter future for patients. The fight against melanoma continues, but the advancements offer hope for a future where this disease is no longer a death sentence.

Date :
  1. Date Completed 2018-03-13
  2. Date Revised 2023-10-11
Further Info :

Pubmed ID

29405038

DOI: Digital Object Identifier

PMC6491081

Related Literature

Article Analysis
・Effective treatment of melanoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.